Adaptive Biotechnologies Q1 Loss decreases, beats estimates

May 07, 2024 — 04:53 pm EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Adaptive Biotechnologies (ADPT) reported Loss for first quarter that decreased from last year and beat the Street estimates.

The company's earnings came in at -$47.5 million, or -$0.33 per share. This compares with -$57.7 million, or -$0.40 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$0.34 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 11.4% to $41.9 million from $37.6 million last year.

Adaptive Biotechnologies earnings at a glance (GAAP) :

-Earnings (Q1): -$47.5 Mln. vs. -$57.7 Mln. last year. -EPS (Q1): -$0.33 vs. -$0.40 last year. -Revenue (Q1): $41.9 Mln vs. $37.6 Mln last year.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Adaptive Biotechnologies Q1 Loss decreases, beats estimates

Tags

Latest Articles